Endogenous MiRNA Sponge LincRNA-ROR Promotes Proliferation, Invasion and Stem Cell-like Phenotype of Pancreatic Cancer Cells
Overview
Authors
Affiliations
The long intergenic non-coding RNA, regulator of reprogramming (linc-ROR) is an oncogene and plays a key role in the embryonic stem cell maintenance and is involved in cancer progression. The objective of this study was to analyze linc-ROR expression in pancreatic ductal adenocarcinoma (PDAC) and determine the regulation effects of linc-ROR on proliferation and invasion of cancer cells, as well as properties of cancer stem-like cells (CSLCs). In this study, we found that linc-ROR was up-regulated in PDAC tissues and related to poor prognosis. Linc-ROR knockdown in pancreatic cancer cells inhibited cell growth and arrested in G1 phrase. Suppressed linc-ROR expression also attenuated cancer cell migration, invasion, and epithelial-mesenchymal transition. We observed that linc-ROR expression was increased in CSLCs. Importantly, linc-ROR knockdown impaired the properties and tumorigenesis of pancreatic CSLCs . Mechanistically, we found that linc-ROR functioned as a competing endogenous RNA (ceRNA) to several tumor suppressor microRNAs, particularly some members of let-7 family. We conclude that, as a crucial oncogene, linc-ROR promotes cell proliferation, invasiveness and contributes to stem cell properties of CSLCs in PDAC via acting as a ceRNA to regulate function of microRNAs. The linc-ROR is a potential therapeutic target for PDAC.
Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A Heliyon. 2024; 10(15):e35208.
PMID: 39170516 PMC: 11337742. DOI: 10.1016/j.heliyon.2024.e35208.
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.
PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.
Yan Y, Wang J, Xu B, Ni J, Dai T, Wang L J Cancer. 2024; 15(11):3321-3337.
PMID: 38817864 PMC: 11134441. DOI: 10.7150/jca.95014.
Trifylli E, Kriebardis A, Koustas E, Papadopoulos N, Fortis S, Tzounakas V Int J Mol Sci. 2024; 25(6).
PMID: 38542378 PMC: 10969997. DOI: 10.3390/ijms25063406.
Yu X, Ma X, Jia Y, Wu X, Yan Z Cell Transplant. 2023; 32:9636897231178902.
PMID: 37306240 PMC: 10272685. DOI: 10.1177/09636897231178902.